Genedrive Share Discussion Threads

[hooded claw] 10/2/2021 08:40

I think it is great the way the MMs make it look like the share price is struggling one day only to show the real picture the next day.Don't be fooled by the games. They want your shares

[babbler] 10/2/2021 08:37

Buyers buying. Great comment right.

[bunz3] 10/2/2021 08:34

Another large buy at £1.45

[oilisgold] 10/2/2021 08:34

Sellers selling

[qs99] 10/2/2021 08:33

£80m market cap now, but if test sales start motoring then it can still multi-bag from here in a major way IMO....DYOR as ever, but NCYT showed the way on what can happen to a market cap once that starts to happen

Cheers
QS99

[aquilla] 10/2/2021 08:33

American interest:

Genedrive Inks Distribution Agreement With Beckman Coulter for SARS-CoV-2 PCR Tests
Feb 08, 2021 | staff reporter

NEW YORK – Genedrive announced on Monday that it has entered a distribution agreement with Beckman Coulter Life Sciences to sell and distribute Genedrive's SARS-CoV-2 kit.
Under the agreement, Danaher subsidiary Beckman Coulter will sell and distribute Genedrive's 96 SARS-CoV-2 test in the US and Europe for use on upper respiratory viral samples. The companies are planning to launch the test commercially in mid-February, Genedrive said in a statement.
Financial and other terms of the agreement were not disclosed.
The new agreement comes after a collaboration agreement between the two companies in August to develop a fully automated PCR test for Beckman Coulter's Biomek instrument and used with the firm's RNAdvance Viral XP extraction kit.
Manchester, UK-based Genedrive's test is "ideally suited" for use on the Biomek i7 instrument, Genedrive said. The test "removes many of the fluid dispensing steps" of other PCR tests, the company added.
According to Indianapolis-based Beckman Coulter, its Biomek instrument could process approximately 1,000 samples per day.
The Genedrive 96 SARS-CoV-2 test was CE marked in May 2020. Genedrive applied for Emergency Use Authorization from the US Food and Drug Administration the same month, but due to the delay, Genedrive will import the test while the EUA is under review, a spokesperson for the company said.

[bunz3] 10/2/2021 08:32

20,000 share buy at £!.45

[1msi] 10/2/2021 08:31

304,892 trade just published... time to move up again

[bunz3] 10/2/2021 08:31

Actybod, also no interest in selling ,as Mid month drawing closer

[actybod] 10/2/2021 08:29

? HL 143.25. Not selling.

[bunz3] 10/2/2021 08:29

IF USA BUYERS START BUYING from after mid February

how much of a demand for shares then

[bunz3] 10/2/2021 08:28

AS THIS MOVES UP MORE AS GETTING CLOSER TO MID MONTH

SHORTER IN A PANIC

[oilisgold] 10/2/2021 08:28

Now Again NT TO SELL

[oilisgold] 10/2/2021 08:28

Being pumped to let big sellers out

[oilisgold] 10/2/2021 08:27

LOSS MAKING COMPANY, AND MARKETCAP TOO HIGH

[bunz3] 10/2/2021 08:27

shorter in a panic as this moves up more

[oilisgold] 10/2/2021 08:27

Big sellers selling up.

[oilisgold] 10/2/2021 08:27

Last time THIS WAS PUMPED TO 300P AND THEN PLACING.

AGAIN THE SAME HAPPENING

[oilisgold] 10/2/2021 08:26

This is BEING PUMPED

[bunz3] 10/2/2021 08:25

how silly for you to short this
as getting closer to mid month


so many buyers who have read rns

[oilisgold] 10/2/2021 08:23

How big will the DUMP BE?

[oilisgold] 10/2/2021 08:23

BEING PUMPED TO LET BIG SELLERS OUT

[bunz3] 10/2/2021 08:23

with this buying volume ,will £1,50 be seen Today

[oilisgold] 10/2/2021 08:23

Soo many sellers again

[oilisgold] 10/2/2021 08:22

NT TO SELL AGAIN ON LOW VOLUME